interleukin-12 subunit beta antibody (Myosotis)

N/A

Report date: 2025/03/20 15:32:08

Base Information

Drug Nameinterleukin-12 subunit beta antibody (Myosotis)
Drug Alias Nameanti-IL-12p40/IL-23p40 antibodies (University of Zurich)interleukin-12 subunit beta antibody (University of Zurich)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionInterleukin-12 subunit beta inhibitorsBeta amyloid A4 protein inhibitors
TargetsBeta amyloid A4 proteinInterleukin-12 subunit beta
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Zurich
China Registration ClassN/A

Develop Information

Active CompaniesMyosotis Therapeutics Ag
Inactive CompaniesUniversity of Zurich
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A